Liver Cancer Clinical Trials in San Jose, CA

33 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial	Phase 3	NRG Oncology	9 mi
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients	—	University of California, San Diego	16 mi
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	Phase 3	Children's Oncology Group	16 mi
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer	Phase 1/2	Teclison Ltd.	16 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors	Phase 1/2	Children's Oncology Group	16 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma	Phase 3	AstraZeneca	16 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI	N/A	VA Office of Research and Development	16 mi
REGULUS: MRI-guided Adaptive SABR for Liver Cancers	Phase 2	Stanford University	16 mi
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology	—	Palo Alto Veterans Institute for Research	16 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors	Phase 1/2	Tango Therapeutics, Inc.	16 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors	Phase 1	Exelixis	16 mi
Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90	—	Palo Alto Veterans Institute for Research	16 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations	Phase 1	Tyra Biosciences, Inc	17 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis	Phase 2	Genentech, Inc.	17 mi
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies	Phase 1	BioEclipse Therapeutics	17 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	17 mi
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma	—	Stanford University	17 mi
National Liver Cancer Screening Trial	Phase 4	University of Texas Southwestern Medical Center	22 mi
The Vanguard Study: Testing a New Way to Screen for Cancer	N/A	National Cancer Institute (NCI)	22 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors	Phase 2	SWOG Cancer Research Network	25 mi
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)	—	Travera Inc	39 mi
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor	Phase 1/2	Eisai Inc.	41 mi
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers	N/A	University of California, San Francisco	41 mi
Observational Study Protocol: LIVER-R	—	AstraZeneca	41 mi
A Multicenter Cancer Biospecimen Collection Study	—	Cofactor Genomics, Inc.	42 mi
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma	Phase 2	Allison O'Neill, MD	42 mi
HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients	N/A	University of California, San Francisco	42 mi
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer	—	National Cancer Institute (NCI)	42 mi
HEalth Advocate for Liver Transplant - Pilot	N/A	University of California, San Francisco	42 mi
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma	Phase 2	Mary Feng, MD	42 mi
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma	Phase 1/2	Eureka Therapeutics Inc.	42 mi
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)	Phase 1/2	Hoffmann-La Roche	42 mi
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform	—	Elephas	47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.